What a shocking development. With small pulses of electricity, scientists have merged human-tumor and immune cells to create personalized vaccines against a deadly cancer.
In the first trial of this strategy in people, 7 of 17 patients with kidney cancer that had spread to other tissues developed tumor-specific immune responses after several vaccinations with the fused cells.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.